Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Category Archives: Top 20 Shareholders

Top 20 Shareholders September 2018

News & Announcements 2018, Top 20 ShareholdersBy Richard MollardSeptember 24, 2018

Top 20 Shareholders Report_ 25Sept2018

Top 20 Shareholders August 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustAugust 17, 2018

Top 20 Shareholders August 2018

Top 20 Shareholders July 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustJuly 13, 2018

Top_Holders_Report (4)

Top 20 Shareholders June 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustJune 10, 2018

Top 20 04.06.18

Top 20 Shareholders April 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustApril 27, 2018

Top 20 Share Holders April 2018

Top 20 Shareholders Feb 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy Richard HopkinsFebruary 26, 2018

Top holder 20_Feb 2018

12345
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on TwitterPharmAust Retweeted
epichemEpichem@epichem·
29 Jun

𝐖𝐄𝐋𝐂𝐎𝐌𝐄 Fiona Milner!

Today we are rolling out the red carpet as Fiona Milner joins Epichem Pty Ltd as General Manager. The Epichem team are thrilled to have Fiona on board and we look forward to working with her.

#teamepichem

Reply on Twitter 1541992242344333312Retweet on Twitter 15419922423443333121Like on Twitter 15419922423443333125Twitter 1541992242344333312
Load More...
Copyright © 2020 Pharmaust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top